{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:02:45Z","timestamp":1790301765834,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00296-015-3258-5","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T03:52:17Z","timestamp":1427082737000},"page":"1307-1310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Correlation between P2X7 receptor gene polymorphisms and gout"],"prefix":"10.1007","volume":"35","author":[{"given":"Qiong-yao","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"issue":"4","key":"3258_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","volume":"78","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Horsburgh S (2014) Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 78(4):245\u2013251","journal-title":"Maturitas"},{"issue":"3","key":"3258_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semarthrit.2013.04.007","volume":"43","author":"JH Tao","year":"2013","unstructured":"Tao JH, Zhang Y, Li XP (2013) P2X7R: a potential key regulator of acute gouty arthritis. Semin Arthritis Rheum 43(3):376\u2013380","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"3258_CR3","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","volume":"176","author":"D Ferrari","year":"2006","unstructured":"Ferrari D, Pizzirani C, Adinolfi E et al (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176(7):3877\u20133883","journal-title":"J Immunol"},{"key":"3258_CR4","first-page":"39","volume":"4","author":"SR Kingsbury","year":"2011","unstructured":"Kingsbury SR, Conaghan PG, McDermott MF (2011) The role of the NLRP3 inflammasome in gout. J Inflamm Res 4:39\u201349","journal-title":"J Inflamm Res"},{"issue":"1","key":"3258_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11926-013-0392-5","volume":"16","author":"S Steiger","year":"2014","unstructured":"Steiger S, Harper JL (2014) Mechanisms of spontaneous resolution of acute gouty inflammation. Curr Rheumatol Rep 16(1):392","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 1","key":"3258_CR6","doi-asserted-by":"crossref","first-page":"i81","DOI":"10.1136\/ard.59.suppl_1.i81","volume":"59","author":"WB Berg Van den","year":"2000","unstructured":"Van den Berg WB (2000) Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 59(Suppl 1):i81\u2013i84","journal-title":"Ann Rheum Dis"},{"key":"3258_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","volume":"28","author":"KL Rock","year":"2010","unstructured":"Rock KL, Latz E, Ontiveros F et al (2010) The sterile inflammatory response. Annu Rev Immunol 28:321\u2013342","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3258_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","volume":"9","author":"KL Rock","year":"2013","unstructured":"Rock KL, Kataoka H, Lai JJ (2013) Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9(1):13\u201323","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"3258_CR9","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","volume":"56","author":"RM Pope","year":"2007","unstructured":"Pope RM, Tschopp J (2007) The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56(10):3183\u20133188","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3258_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.0105-2896.2009.00860.x","volume":"233","author":"F Martinon","year":"2010","unstructured":"Martinon F (2010) Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 233(1):218\u2013232","journal-title":"Immunol Rev"},{"issue":"1","key":"3258_CR11","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4159","volume":"15","author":"RA Terkeltaub","year":"2013","unstructured":"Terkeltaub RA, Schumacher HR, Carter JD et al (2013) Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Res Ther 15(1):R25","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"3258_CR12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","volume":"71","author":"N Schlesinger","year":"2012","unstructured":"Schlesinger N, Alten RE, Bardin T et al (2012) Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 71(11):1839\u20131848","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3258_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuropharm.2008.06.067","volume":"56","author":"MF Jarvis","year":"2009","unstructured":"Jarvis MF, Khakh BS (2009) ATP-gated P2X cation-channels. Neuropharmacology 56(1):208\u2013215","journal-title":"Neuropharmacology"},{"key":"3258_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fncel.2013.00273","volume":"7","author":"T Chataigneau","year":"2013","unstructured":"Chataigneau T, Lemoine D, Grutter T (2013) Exploring the ATP-binding site of P2X receptors. Front Cell Neurosci 7:273","journal-title":"Front Cell Neurosci"},{"key":"3258_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2012.00116","volume":"3","author":"RM Rumney","year":"2012","unstructured":"Rumney RM, Wang N, Agrawal A et al (2012) Purinergic signalling in bone. Front Endocrinol (Lausanne) 3:116","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3258_CR16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","volume":"452","author":"JR Gever","year":"2006","unstructured":"Gever JR, Cockayne DA, Dillon MP et al (2006) Pharmacology of P2X channels. Pflugers Arch 452(5):513\u2013527","journal-title":"Pflugers Arch"},{"issue":"56","key":"3258_CR17","doi-asserted-by":"crossref","first-page":"pe6","DOI":"10.1126\/scisignal.256pe6","volume":"2","author":"A Trautmann","year":"2009","unstructured":"Trautmann A (2009) Extracellular ATP in the immune system: more than just a \u201cdanger signal\u201d. Sci Signal 2(56):pe6","journal-title":"Sci Signal"},{"issue":"2","key":"3258_CR18","first-page":"141","volume":"17","author":"T Eleftheriadis","year":"2013","unstructured":"Eleftheriadis T, Pissas G, Karioti A et al (2013) Uric acid induces caspase-1 activation, IL-1\u03b2 secretion and P2X7 receptor dependent proliferation in primary human lymphocytes. Hippokratia 17(2):141\u2013145","journal-title":"Hippokratia"},{"issue":"9","key":"3258_CR19","doi-asserted-by":"crossref","first-page":"10953","DOI":"10.3390\/molecules180910953","volume":"18","author":"LA Alves","year":"2013","unstructured":"Alves LA, Bezerra RJ, Faria RX et al (2013) Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain. Molecules 18(9):10953\u201310972","journal-title":"Molecules"},{"key":"3258_CR20","doi-asserted-by":"crossref","first-page":"954530","DOI":"10.1155\/2014\/954530","volume":"2014","author":"TM Kvist","year":"2014","unstructured":"Kvist TM, Schwarz P, J\u00f8rgensen NR (2014) The P2X7 receptor: a key player in immune-mediated bone loss? Sci World J 2014:954530. doi: 10.1155\/2014\/954530","journal-title":"Sci World J"},{"issue":"1","key":"3258_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12026-011-8203-4","volume":"50","author":"LY Lenertz","year":"2011","unstructured":"Lenertz LY, Gavala ML, Zhu Y et al (2011) Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol Res 50(1):22\u201338","journal-title":"Immunol Res"},{"issue":"26","key":"3258_CR22","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1073\/pnas.0308558101","volume":"101","author":"C Andrei","year":"2004","unstructured":"Andrei C, Margiocco P, Poggi A et al (2004) Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 101(26):9745\u20139750","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3258_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/187152711794488638","volume":"10","author":"SD Skaper","year":"2011","unstructured":"Skaper SD (2011) Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol Disord Drug Targets 10(1):44\u201356","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"3258_CR24","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L, Fuller SJ, Sluyter R et al (2010) Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 24(8):2916\u20132927","journal-title":"FASEB J"},{"issue":"1","key":"3258_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.175.1.82","volume":"175","author":"G Cabrini","year":"2005","unstructured":"Cabrini G, Falzoni S, Forchap SL et al (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 175(1):82\u201389","journal-title":"J Immunol"},{"issue":"14","key":"3258_CR26","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M010353200","volume":"276","author":"BJ Gu","year":"2001","unstructured":"Gu BJ, Zhang W, Worthington RA et al (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 276(14):11135\u201311142","journal-title":"J Biol Chem"},{"key":"3258_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2172-13-64","volume":"13","author":"A Wesselius","year":"2012","unstructured":"Wesselius A, Bours MJ, Arts IC et al (2012) The P2X(7) loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels. BMC Immunol 13:64","journal-title":"BMC Immunol"},{"issue":"4","key":"3258_CR28","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","volume":"281","author":"AN Shemon","year":"2006","unstructured":"Shemon AN, Sluyter R, Fernando SL et al (2006) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281(4):2079\u20132086","journal-title":"J Biol Chem"},{"issue":"30","key":"3258_CR29","doi-asserted-by":"crossref","first-page":"31287","DOI":"10.1074\/jbc.M313902200","volume":"279","author":"BJ Gu","year":"2004","unstructured":"Gu BJ, Sluyter R, Skarratt KK et al (2004) An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 279(30):31287\u201331295","journal-title":"J Biol Chem"},{"issue":"6","key":"3258_CR30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpsychires.2009.10.005","volume":"44","author":"S Roger","year":"2010","unstructured":"Roger S, Mei ZZ, Baldwin JM et al (2010) Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res 44(6):347\u2013355","journal-title":"J Psychiatr Res"},{"issue":"2","key":"3258_CR31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","volume":"64","author":"FA Amaral","year":"2012","unstructured":"Amaral FA, Costa VV, Tavares LD et al (2012) NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum 64(2):474\u2013484","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3258_CR32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.humimm.2010.05.008","volume":"71","author":"L Portales-Cervantes","year":"2010","unstructured":"Portales-Cervantes L, Ni\u00f1o-Moreno P, Don\u00edz-Padilla L et al (2010) Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum Immunol 71(8):818\u2013825","journal-title":"Hum Immunol"},{"issue":"4","key":"3258_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm.2710","volume":"18","author":"RE Sorge","year":"2012","unstructured":"Sorge RE, Trang T, Dorfman R et al (2012) Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 18(4):595\u2013599","journal-title":"Nat Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3258-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3258-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3258-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:30:46Z","timestamp":1566444646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3258-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3258"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3258-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}